Posts tagged “LabCorp”
BD reboots startup program; NePhroGenex clinical trial; Red Hat Summit; OxyBio update; LabCorp board shuffle
In the latest Bulldog roundup of life science and technology news: BD Technologies re-launches incubator program; NePhroGenex reports a loss for 2013 but secures providers for big clinical trial; Red Hat adds IBM exec to Summit lineup; OxyBio can resume testing; and LabCorp shuffles board.
Google Glass goes for style; Box plans IPO; nCino, LabCorp name new execs; Disney makes YouTube play
The latest Bulldog roundup: Google Glass goes for fashion in deal with Ray-Ban, Oakley; web storage startup Box is going public; cloud banking firm nCino adds a VP for revenue and strategy; LabCorp hires a new CFO; and Disney is buying Maker Studios for $500 million.
LabCorp (NYSE:LH) processed more tests in the fourth quarter than it did same period in the prior year but it made less money per test and the laboratory testing and diagnostics firm's revenue and earnings results fell short of analyst estimates.
LabCorp is among the first laboratories offering NanoString Technologies' prognostic breast cancer test, which has been shown in studies to offer better information compared to existing cancer assays.
Myriad Genetics, the company that went all the way to the U.S. Supreme Court seeking patents on human genes, now claims LabCorp's new genetic tests for breast cancer infringe on its patents. Read more about the suit.
Garheng Kong, a former partner at venture capital firm Intersouth Partners in Durham, is the newest member of the board at lab testing giant LabCorp.
The Burlington-based company's latest deal - $241 million for Medtox Scientific - is just the latest in a series of acquisitions made over the past three years.
Burlington-based LabCorp will work with XDx to develop a biomarker and commercialize a test for the flares -- extended periods of activity for the autoimmune disease. Lupus causes the body's immune system to attack its own tissues, which leads to inflammation and organ damage.
Alzheimer's disease affects more than five million people in the United States and more than 35 million worldwide. There are no specific tests available to detect Alzheimer's disease and track its progression. Diagnosis is currently conducted by behavioral and cognitive measurements.
- No-tipping trend now at more restaurants, with mixed results
- iRobot CEO says vacuum cleaners clear path to robot future
- Samsung updates smartwatch, Lenovo ditches laptop keyboard
- Survey: US companies add a solid 177,000 jobs in August
- Ex-NCSU football players seeking $200,000 for startup Gryppers (+ video)